This study examined six needle-free injection ports comprising three taps (Sorenson Intralock® , Top type L, Viggo Connecta®), a one-way valve (Braun RV 1000) and two cannulae with integral injection ports (Vasofix, Venflon® 2) with regard to deadspace, protection against blood spillage, and potential difficulties in use. A conventional bung (Baxter), requiring needle use for drug administration, was included for comparison. Where necessary, ports were combined with cannulae in order to simulate clinical practice and allow fair comparison with the Vasofix and Venflon cannulae. Total deadspace was then calculated by filling with normal saline and measuring weight increase. Deadspace (0.10 to 0.43 ml) varied with injection port type and cannula size. Such volumes can contain significant amounts of drug and may be hazardous if not flushed after injection. Only the Vasofix and Venflon Cannulae and the Braun R VI 000 protected adequately against blood spillage. Costs varied widely (A$0.I9 to A$2.20 excluding cannula). The Vasofix and Venflon 2 cannulae were found to be nearest the ideal.
Inoculation of blood through needlestick injury or cuts and abrasions on the skin is the major risk factor for AIDS and hepatitis B to which anaesthetists are exposed. Although current data suggest the risk of seroconversion to HIV after a single needlestick exposure is less than 1 %, Jones 1 has suggested that this may be equal to a 1 in 25 chance of becoming infected in a forty-year working life.
Clearly these odds can be improved by reducing as much as possible the use of needles in anaesthetic practice. Until recently, it has been common to cap cannulae with bungs incorporating a rubber membrane which require repeated needle use for drug administration. Injection devices which allow direct attachment of the syringe to the cannula without need for a needle reduce the risk of needlestick injury and are becoming increasingly popular.
Ideally, any such device should have a low deadspace, be securely attached to the cannula to prevent disconnection and blood spillage, prevent reflux of blood and be cheap. This study examined a selection of available needle-free injection devices -three different three-way taps, a one-way valve, two cannulae with integral valved injection side ports, and a conventional rubber membrane bung, particularly in relation to their functional deadspace. An assessment was also made of their ease of use and of potential difficulties they might introduce into clinical practice. METHOD The devices evaluated were the Sorenson Intralock® tap, the Top 3-way Stopcock Type L, the Viggo Connecta® 3-way tap, the Braun Back Check Reflux Valve RV1000, the Vasofix® and Venflon® 2 cannulae, each with integral valved injection side port, and the Baxter Injection Site Luer Lock, included as a control because it is one of the type of device requiring a needle for drug administration. Full product information is given in Appendix 1.
To measure deadspace relevant in clinical practice and so reflect deadspace volumes which could subsequently be delivered to patients, each device was attached to a cannula where appropriate (the injection port is an integral part of the Vasofix® and Venflon® 2 cannulae). Three different gauges of cannula (22G, 18G, 14G) were used to determine the importance of cannula size on total deadspace. In addition, two different makes of cannula were tested -Insyte® and Jelco® . The combined cannula/injection port was N. G. SMART weighed on a Sauter 414-51 balance, accurate to 0.0001 g, before and after filling with normal saline. A 2 n11 syringe was used for filling and this was removed before measurement. Every attempt was made to remove bubbles and the exterior of the device was carefully dried before weighing. The deadspace was calculated by subtracting the dry weight from the wet weight and converting weight to volume by assuming 1 g of 0.9% NaCI at room temperature is equal to 0.995 ml. Ten different injection devices of each type in combination with ten cannulae of each size were tested. In the case of the Viggo Connecta® ,which allows injection from a second port simultaneously, the tap to this port was closed so that it did not fill. This gave a more accurate reflection of the deadspace which would be present in clinical use. Injection into the Baxter Injection Site Luer Lock was made, with a 23 gauge Terumo needle which was withdrawn before measurement. The Vasofix® and Venflon® 2 cannulae were capped with the closing caps supplied and filled via their integral injection ports.
RESULTS
The mean volume of each injection device when attached to the three sizes of Insyte and Jelco cannulae is shown in Figures 1 a and b . The results for the Vasofix and Venflon 2 cannulae are shown in Figure 2 . Deadspace is seen to be more dependant on cannula size than manufacturer with volume increasing with gauge, and on the injection port use. If needle use is to be avoided, only the Venflon 2 cannula has a deadspace similar to the Baxter Injection Site Luer Lock attached to an equivalently sized cannula. All the other devices have a larger deadspace at every cannula size.
Information regarding deadspace is not included in the manufacturer's packaging.
Injection ports should be securely attached to the cannula and prevent accidental backflow of blood to minimise the risk of skin contamination from blood spillage. Only the Top Type L has a push fit which can allow disconnection. All the others have Luer locks which are more secure. The Sorenson, Top and Viggo 3-way taps can all allow reflux if the tap is turned the wrong way. The Braun reflux valve and Vasofix and Venflon 2 cannulae have an injection valve to prevent this under normal circumstances. Drugs can be administered into a running drip when the Viggo Connecta® tap and Vasofix® and Venflon 2 cannulae are used but fluid flow must be interrupted with the Sorenson and Top 3-way taps. The Braun reflux valve allows gravity flow of fluids but at the expense of being able to inject drugs. Fluids cannot be administered if the Baxter Injection Site Luer lock is used.
A comparison of the cost of injection ports and cannulae is made in Table 1 . Table 2 summarises the features of the devices tested. deadspace than a conventional rubber bung and this deadspace can contain a significant amount of drug. There may therefore be a release of drug into the circulation at the next injection causing unwanted effects, the delivery of an inadequate dose, or the mixing of drugs injected consecutively. Small doses of many drugs can be surprisingly active. Several authors have reported that low doses of d-tubocurarine 2 (0.05 mg/kg), pancuronium 3 (0.007 mglkg), atracurium 3 (0.025 mg/kg) and vecuronium 4 (0.005-0.010 mg/kg) can cause distressing symptoms such as ptosis, blurring of vision, and difficulty in breathing in a large proportion of patients, with a measurable degree of respiratory impairment in a significant number of them. Morever, the effect of this size of dose may be more pronounced in the partially reversed patient. Problems may then occur after the patient has left theatre subsequent to the next injection of any drug or administration of intravenous fluids. Thus, for example, only 0.138 ml of vecuronium at a standard dilution of 2 mglrnl is required to produce significant neuromuscular block in a 55 kg patient.
Only the 22 gauge Jelco combined with a conventional Baxter bung and the equivalent 22 gauge Venflon have a deadspace significantly smaller than this. Depolarising relaxants are also extremely potent. The ED95 for suxamethonium in adults with normal plasma cholinesterase varies between 0.2-0.3 mg/kg, much less than the 1-1.5 mg/kg used for tracheal intubation. 5 Thus a volume of 0.22 mg (11 mg) is sufficient to produce block in a 55 kg adult. This volume is less than the deadspace found in many of these injection port and cannula combinations. If suxamethonium remains in the deadspace, the volume flushed into the circulation at the next injection may also be sufficient to produce bradycardia or junctional rhythm. Williams et al. 6 have demonstrated that 0.2 ml (10 mg) does so when injected as a repeat dose. In children, bradycardia is produced at even lower doses with one recorded case occurring in a twomonth infant after 4 mg (0.08 ml).? This demonstrates an additional point; that the large deadspace of these injection ports may be even more significant in paediatric practice.
The likelihood of drug mixing also increases as deadspace increases. Alcuronium, d-tubocurarine, pancuronium and atracurium all form precipitates when administered through the same cannula as thiopentone. 8 Yes No aggregate anaphylaxis. The effect is most marked with thiopentone and atracurium. 9 One way of minimising these problems would be to dilute all potent drugs by a factor of say tenfold before use or more simply to flush with saline after each use. Alternatively, drugs may be injected into a running drip, although this is only possible with three of the devices (Viggo, Vasofix and Venflon 2).
Injection ports might increase the risk of nosocomial infection due to the possibility of bacterial growth in the deadspace material. Although this might be expected to increase the risk of cannula-related infection, no study has proved this to be clinically significant. The Baxter injection site Luer lock offers the theoretical advantage of having a latex membrane which can be cleaned with bactericide while the other devices retain a meniscus of fluid after each injection which cannot be cleaned.
In summary, the use of needle-free injection ports is expected to become increasingly common in order to reduce the risk of needlestick injury to anaesthetic personnel. Most ports have a larger deadspace than conventional bungs and the anaesthetist should be aware of this and take measures to prevent retention of drug in and subsequent delivery from this space. Not all give protection against blood spillage. The ideal device should be safe from disconnection and prevent accidental backflow of blood as well as being oflow cost. Of the devices tested here, the Vasofix and Venflon 2 cannulae, with their integral injection ports, come nearest to the ideal.
